Fig. 4From: Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edemaMean visual acuity measurements in group 2 throughout study. Line chart illustrating the logMAR visual acuity in group 2 throughout the study period. All comparisons revealed insignificant changes. Significant improvement in VA was found shortly after 2nd switch before it was rapidly lostBack to article page